HY profit attributable RMB145.4 mln up approximately 20 pct
Aug 30 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK : * Pharmaceutical group- HY revenue amounted to RMB 451.9 million representing an increase of approximately 16.7% * HY profit attributable amounted to RMB145.4 million representing an increase of approximately 20.0% * Says the board has declared the payment of an interim dividend of RMB0.045 per share * Source text for Eikon ID:nHKS9Q4NLW * ((Further company coverage: 1681.HK )) ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director